These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38126537)

  • 1. The level of Tim-3+CD8+ T cells can serve as a potential marker for evaluating the severity of acute graft-versus-host disease after haplo-PBSCT.
    Pang N; Yu M; Xu J; Yuan H; Chen G; Wang D; Han C; Wang W; Ding J; Jiang M
    Braz J Med Biol Res; 2023; 56():e12997. PubMed ID: 38126537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
    Pang N; Tudahong S; Zhu Y; He J; Han C; Chen G; Wang W; Wang J; Ding J
    Immun Inflamm Dis; 2024 Feb; 12(2):e1177. PubMed ID: 38353382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of CD8
    Zhang AD; Wei XX; Guo JY; Jin XS; Zhang LL; Li F; Gu ZY; Bo J; Dou LP; Liu DH; Li M; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):896-905. PubMed ID: 38926986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and risk factors analysis of acute graft-versus-host disease in patients with related HLA-haploidentical non T cell-depleted in vitro peripheral hematopoietic stem cell transplantation].
    Xue W; Jiang M; Tian M; Duan X; Qu J; Yuan H; Xu J; Wen B; Li L; Wang Y; Liu Y; Wang X; Cao H
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1100-6. PubMed ID: 25543706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.
    Yin J; Li L; Wang C; Zhang Y
    Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation.
    Delia M; Carluccio P; Mestice A; Chiusolo P; Metafuni E; Bellesi S; Arpinati M; Milone GA; Martino M; Mazza P; Ingrosso C; Vacca A; Saporiti G; Zallio F; Attolico I; Pastore D; Specchia G; Albano F; Musto P
    Transplant Cell Ther; 2021 Nov; 27(11):918.e1-918.e9. PubMed ID: 34403789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis.
    Zhao H; Ma Y; Tian F; Li B; Xiao N; Mo X; Aibibula M; Min H; Cai X; Zhang T; Ma X
    Exp Parasitol; 2023 Nov; 254():108623. PubMed ID: 37793539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
    Stocker N; Duléry R; Battipaglia G; Brissot E; Médiavilla C; Sestili S; Paviglianiti A; Ledraa T; Mohty R; Bazarbachi A; Belhocine R; Vekhoff A; Ruggeri A; Mohty M; Malard F
    Eur J Haematol; 2019 Jul; 103(1):10-17. PubMed ID: 30958904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
    Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The correlated research of acute graft versus host disease after allogeneic stem cell transplantation].
    Yang F; Chen H; Liu GX; Lu M; Feng K; Zhang YG; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):264-8. PubMed ID: 16875562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
    Ding L; Zhu H; Yang Y; Yan HM; Zhang HH; Han DM; Wang ZD; Zheng XL; Liu J; Zhu L; Mei-Xue ; Guo ZK; Wang HX
    Leuk Res; 2017 May; 56():13-20. PubMed ID: 28161606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of Tim-3 mRNA in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Li XL; Yao Y; Yang BY; Xu LJ; Liu B; Che M; Zhu YB; Wu XJ; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):469-73. PubMed ID: 27431070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
    Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation by the level of galectin-9 in peripheral blood].
    Yin J; Cao Y; Zhou JF; Zhang YC
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):23-27. PubMed ID: 32023750
    [No Abstract]   [Full Text] [Related]  

  • 16. The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantation.
    Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
    Pediatr Transplant; 2020 Nov; 24(7):e13793. PubMed ID: 32741088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 19. Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day +30 after allo-HSCT.
    Drokov MY; Davydova JO; Kuzmina LA; Galtseva IV; Kapranov NM; Vasilyeva VA; Dubnyak DS; Koroleva OM; Mikhalcova ED; Popova NN; Parovichnikova EN; Savchenko VG
    Leuk Res; 2017 Mar; 54():25-29. PubMed ID: 28095351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Characteristics of T Lymphocyte Reconstitution after Haploid Hematopoietic Stem Cell Transplantation in SAA and Its Relationship with aGVHD].
    Tian Q; Zhu QJ; Wang T; Gong R; Tian WW; Gao ZL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):532-538. PubMed ID: 37096530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.